1Enomoto K, Nakamichi I, Hamada K, et al. Unicentric and muhicenteic Castleman's disease [J]. Br J Radiol, 2007, 80(949): 24-26.
2Castleman B. Case records of the Massachusetts General Hospital: weekly clinicopathologic exercises (case 40011)[J]. N Engl J Med, 1954, 250 (1) : 26-30.
9Park JB, Hwang JH, Kim H, et al. Castleman disease presenting with jaundice: a case with the multicentric hyaline vascular variant [J]. Korean J Intern Med, 2007, 22(2): 113-117.
3Higuchi T, Nakanishi T,Takada K, et al. A case of muhicen- tric Castleman's disease having lung lesion successfully treated with humanized anti-interleukin-6 receptor antibody, tocilizumab[J]. J Korean Med Sci, 2010,25(9): 1364-1367.
4Sun X,Han B. Muhicentric Castleman's disease present- ing with multiple nodes in lungs:a case report and litera- ture review[J]. Int J Hematol, 2008,88(3) : 278-282.
6Lee ES,Paeng JC,Park CM,et al. Metabolic characteristics of Castleman disease on 18F-FDG PET in relation to clini- cal implication[J]. Clin Nucl Med, 2013,38(5) : 339-342.
7Baranzelli A,Akkad R,Bourhindhomme B,el al.Castleman's disease:unu.siial presentahOn of Castleman's ilisease and review of literature[J].Kev Pneumol Clin,2013,69(1):55-59.
